In this paper we analyse so-called ‘killer acquisitions’ and other detrimental collaborations. Firstly, by analysing economic doctrine. Secondly, by looking at the practice in the human medicine industry. Thirdly, we analysed the merger rules, and whether they can identify and catch the...